Skip to main content
National Oxygen Ltd. logo

National Oxygen Ltd. — Investor Relations & Filings

Ticker · 507813 ISIN · INE296D01010 LEI · 98450002EC1F7X6P1L62 BSE.NS Manufacturing
Filings indexed 305 across all filing types
Latest filing 2022-07-25 Regulatory Filings
Country IN India
Listing BSE.NS 507813

About National Oxygen Ltd.

https://www.nolgroup.com/

National Oxygen Ltd. specializes in the production and distribution of industrial and medical gases. The company operates air separation units to manufacture high-purity liquid oxygen, liquid nitrogen, and argon. Its product portfolio also includes dissolved acetylene. These gases serve a diverse range of sectors, including healthcare, steel manufacturing, chemical processing, and electronics. The company focuses on maintaining stringent quality standards for clinical applications while providing bulk supply solutions for heavy industrial requirements. It utilizes specialized cryogenic tankers for the transport of liquefied gases to ensure efficient delivery and storage at client sites.

Recent filings

Filing Released Lang Actions
Submission of Outcome of Board Meeting for Unaudited Financial Results for the Quarter ended 30th June, 2022 and fixing of AGM date & time.
Regulatory Filings
2022-07-25 English
NATIONAL OXYGEN LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2022 ,inter alia, to consider and approve 1) To consider & approve the ....
Regulatory Filings
2022-07-14 English
Intimation of receipt of request from Four Promoters for reclassifying their status from "Promoter and Promoter group Category" to "Public category" shareholders in accordance with Regulation ....
Regulatory Filings
2022-07-14 English
Compliance Certificate Under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th June, 2022.
Regulatory Filings
2022-07-07 English
Intimation of Trading Window Closure for Quarter ended 30.06.2022.
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the Bombay Stock Exchange regarding the closure of the trading window under SEBI (Prohibition of Insider Trading) Regulations, 2015. It informs about the trading window closure period related to the consideration of unaudited financial results for the quarter ended 30 June 2022. There is no actual financial data or report content included, only an announcement about the trading window closure. The document length is short (2370 characters), and it serves as a regulatory compliance notification rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance announcements and notifications.
2022-06-29 English
Regulation 17,17 A,18, 19,20,21,22,23,24, 24A, 25,26,27 and clauses [b] to (i) and (t) of sub-regulation (2) of regulation 46 and para C, D and E of Schedule V shall not apply, Hence the ....
Regulatory Filings
2022-06-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.